Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FANCD2 promotes mitotic rescue from transcription-mediated replication stress in SETX-deficient cancer cells. | Commun Biol | 2022 | 36543851 | PubTator, text mining | PubMed |
| Genome-wide association study identifies novel loci associated with skin autofluorescence in individuals without diabetes. | BMC Genomics | 2022 | 36536295 | PubTator, text mining | PubMed |
| Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy. | Front Oncol | 2022 | 36531044 | PubTator, text mining | PubMed |
| Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysis. | Front Oncol | 2022 | 36531003 | PubTator, text mining | PubMed |
| Primate gastrulation and early organogenesis at single-cell resolution. | Nature | 2022 | 36517595 | PubTator, text mining | PubMed |
| Splicing-Disrupting Mutations in Inherited Predisposition to Solid Pediatric Cancer. | Cancers (Basel) | 2022 | 36497448 | PubTator, text mining | PubMed |
| Clinical Application of Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Prostate Cancer. | Cancers (Basel) | 2022 | 36497408 | PubTator, text mining | PubMed |
| Oxidative Stress Correlates with More Aggressive Features in Thyroid Cancer. | Cancers (Basel) | 2022 | 36497339 | PubTator, text mining | PubMed |
| Identification of a Novel Curcumin Derivative Influencing Notch Pathway and DNA Damage as a Potential Therapeutic Agent in T-ALL. | Cancers (Basel) | 2022 | 36497257 | PubTator, text mining | PubMed |
| The BRCAness Landscape of Cancer. | Cells | 2022 | 36497135 | PubTator, text mining | PubMed |
| The BRCA1 BRCT promotes antisense RNA production and double-stranded RNA formation to suppress ribosomal R-loops. | Proc Natl Acad Sci U S A | 2022 | 36490315 | PubTator, text mining | PubMed |
| RAD18 opposes transcription-associated genome instability through FANCD2 recruitment. | PLoS Genet | 2022 | 36480547 | PubTator, text mining | PubMed |
| Differential association of antioxidative defense genes with white matter integrity in youth bipolar disorder. | Transl Psychiatry | 2022 | 36476443 | PubTator, text mining | PubMed |
| In vitro systems to study inborn errors of immunity using human induced pluripotent stem cells. | Front Immunol | 2022 | 36466870 | PubTator, text mining | PubMed |
| Case report: Undifferentiated sarcoma with multiple tumors involved in Lynch syndrome: Unexpected favorable outcome to sintilimab combined with chemotherapy. | Front Oncol | 2022 | 36457512 | PubTator, text mining | PubMed |
| The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer. | Nat Genet | 2022 | 36456881 | PubTator, text mining | PubMed |
| Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer. | Nature | 2022 | 36450981 | PubTator, text mining | PubMed |
| Germline Variants in DNA Damage Repair Genes and HOXB13 Among Black Patients With Early-Onset Prostate Cancer. | JCO Precis Oncol | 2022 | 36446039 | PubTator, text mining | PubMed |
| Design, Synthesis and Pharmacological Evaluation of 2-(3-BenzoyI-4-Hydroxy-1,1-Dioxido-2H-Benzo[e][1,2]thiazin-2-yI)-N-(2-Bromophenyl) Acetamide as Antidiabetic Agent. | Drug Des Devel Ther | 2022 | 36444273 | PubTator, text mining | PubMed |
| SMARCA4-Deficient Undifferentiated Tumor: A Rare Malignancy With Distinct Clinicopathological Characteristics. | Cureus | 2022 | 36439610 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=34